We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of ETC-1002, Ezetimibe, and the Combination in Hypercholesterolemic Patients

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01941836
First Posted: September 13, 2013
Last Update Posted: September 11, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Medpace, Inc.
Information provided by (Responsible Party):
Esperion Therapeutics
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2014
  Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Submission: August 13, 2015
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):